Last Updated: November 13, 2026

Nuvo Pharms Company Profile

« Back to Dashboard


What is the competitive landscape for NUVO PHARMS

NUVO PHARMS has twelve approved drugs.

There are four US patents protecting NUVO PHARMS drugs.

Summary for Nuvo Pharms
US Patents:4
Tradenames:11
Ingredients:11
NDAs:12

Drugs and US Patents for Nuvo Pharms

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nuvo Pharms Inc FOLIC ACID folic acid TABLET;ORAL 204418-001 Jul 28, 2015 AA RX No No ⤷  Start Trial ⤷  Start Trial
Nuvo Pharms Inc SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 204071-002 Nov 28, 2014 RX No No ⤷  Start Trial ⤷  Start Trial
Nuvo Pharms Inc SODIUM POLYSTYRENE SULFONATE sodium polystyrene sulfonate POWDER;ORAL, RECTAL 204071-001 Nov 28, 2014 AA RX No No ⤷  Start Trial ⤷  Start Trial
Nuvo Pharms Inc POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 206105-001 Oct 28, 2016 OTC No No ⤷  Start Trial ⤷  Start Trial
Nuvo Pharms Inc CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE chlordiazepoxide hydrochloride; clidinium bromide CAPSULE;ORAL 211421-001 Jul 7, 2020 AB RX No No ⤷  Start Trial ⤷  Start Trial
Nuvo Pharms NUVIGIL armodafinil TABLET;ORAL 021875-001 Jun 15, 2007 AB RX Yes No ⤷  Start Trial ⤷  Start Trial
Nuvo Pharms Inc PENNSAID diclofenac sodium SOLUTION;TOPICAL 020947-001 Nov 4, 2009 DISCN Yes No 8,741,956 ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Expired US Patents for Nuvo Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Nuvo Pharms PROVIGIL modafinil TABLET;ORAL 020717-001 Dec 24, 1998 4,177,290 ⤷  Start Trial
Nuvo Pharms PROVIGIL modafinil TABLET;ORAL 020717-002 Dec 24, 1998 5,618,845 ⤷  Start Trial
Nuvo Pharms PROVIGIL modafinil TABLET;ORAL 020717-002 Dec 24, 1998 4,177,290 ⤷  Start Trial
Nuvo Pharms PROVIGIL modafinil TABLET;ORAL 020717-001 Dec 24, 1998 5,618,845 ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Subscribe to access the full database, or Start Trial

Paragraph IV (Patent) Challenges for NUVO PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 50 mg, 150 mg and 250 mg ➤ Subscribe 2009-07-24
➤ Subscribe Topical Solution 1.5% ➤ Subscribe 2012-07-11
➤ Subscribe Tablets 100 mg and 200 mg ➤ Subscribe 2009-09-11
➤ Subscribe Topical Solution 2.0% ➤ Subscribe 2014-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links